C37 NEW INSIGHTS IN THE EPIDEMIOLOGY, MANAGEMENT, AND OUTCOMES OF CYSTIC FIBROSIS, ILD, AND RESPIRATORY DISEASE: Pirfenidone And Nintedanib Compliance And Persistence In A Real World Setting

Limited real-world data are available on patients' compliance and persistence with these anti-fibrotic medications. Compliance was assessed with the medication possession ratio (MPR) and the proportion of days covered (PDC); dose titration was not considered in these calculations.

Saved in:
Bibliographic Details
Published in:American journal of respiratory and critical care medicine 2017-01, Vol.195
Main Authors: Lalla, D, Bengston, L, Raimundo, K, Korrer, S, Liassou, D, Elliott, C, Limb, S L
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Limited real-world data are available on patients' compliance and persistence with these anti-fibrotic medications. Compliance was assessed with the medication possession ratio (MPR) and the proportion of days covered (PDC); dose titration was not considered in these calculations.
ISSN:1073-449X
1535-4970